Suppliers / Suzhou Homesun Wanqing Pharmaceutical

Suzhou Homesun Wanqing Pharmaceutical

Updated 9 July 2026

Suzhou Homesun Wanqing Pharmaceutical is an API manufacturer. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Imipenem US FDA 1
Meropenem US FDA 1

Also appears on these molecule pages

Meropenem API

Comparing suppliers?

Choose your molecules and target markets. Suzhou Homesun Wanqing Pharmaceutical comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability